Greater age and hepatocellular aging are independent risk factors for hepatocellular carcinoma arising from non-B non-C non-alcoholic chronic liver disease

Pathology International

Volumn 61, Issue 10, 2011, Pages 572-576

  Nakajima, Tomoki ^a   Nakashima, Toshiaki ^a   Yamaoka, Junko ^a   Shibuya, Akiko ^a   Konishi, Eiichi ^a   Okada, Yoshihisa ^b   Jo, Masayasu ^b   Nishikawa, Taichirou ^b   Itoh, Yoshihito ^b   Yoshikawa, Toshikazu ^b  

^a Saiseikai Kyoto Hospital   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Hepatocellular aging; Hepatocellular carcinoma; Non B non C non alcoholic liver disease; Relative nuclear size

Indexed keywords

ALANINE AMINOTRANSFERASE; FERRITIN;

ADULT; AGED; AGING; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CANCER RISK; CELL NUCLEUS; CELLULAR PARAMETERS; CHRONIC LIVER DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; FATTY LIVER; FEMALE; FERRITIN BLOOD LEVEL; HEPATOCELLULAR AGING; HIGH RISK PATIENT; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER BIOPSY; LIVER CELL; LIVER CELL CARCINOMA; LIVER CELL DAMAGE; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER HISTOLOGY; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; NON B NON C NONALCOHOLIC CHRONIC LIVER DISEASE; NONALCOHOLIC FATTY LIVER; NUCLEAR SIZE; PRIORITY JOURNAL; REACTIVE NUCLEAR SIZE; SENESCENCE; THROMBOCYTE COUNT;

AGE FACTORS; AGED; AGING; CARCINOMA, HEPATOCELLULAR; CELL NUCLEUS; CELL NUCLEUS SIZE; CHRONIC DISEASE; DIABETES COMPLICATIONS; FEMALE; HEPATOCYTES; HUMANS; LIVER DISEASES; LIVER NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; REFERENCE VALUES; RISK FACTORS;

EID: 80053338218     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2011.02743.x     Document Type: Article

References (21)

1. Liver Cancer Study Group of Japan. Report of the 16th follow-up survey of primary liver cancer. Acta Hepatol Jpn 2005; 46: 234-54.
2. Hatanaka K, Kudo M, Fukunaga T etal. Clinical characteristics of Non B Non C-HCC: Comparison with HBV and HCV related HCC. Intervirology 2007; 50: 24-31.
3. Davila JA, Morgan RO, Shaib Y etal. Diabetes increases the risk of hepatocellular carcinoma in the United States: A population based case control study. Gut 2005; 54: 533-9.
4. Plentz RR, Caselitz M, Bleck JS etal. Hepatocellular telomere shortening correlates with chromosomal instability and the development of human hepatoma. Hepatology 2004; 40: 80-86.
5. Hepperger C, Otten S, von Hase J, Dietzel S. Preservation of large-scale chromatin structure in FISH experiment. Chromosoma 2007; 116: 117-33.
6. Sekoguchi S, Nakajima T, Moriguchi M etal. Role of cell-cycle turnover and oxidative stress in telomere shortening and cellular senescence in patients with chronic hepatitis C. J Gastroenterol Hepatol 2007; 22: 182-90.
7. Nakajima T, Nakashima T, Okada Y etal. Nuclear size measurement is a simple method for the assessment of hepatocellular aging in non-alcoholic fatty liver disease -comparison with telomere-specific quantitative FISH and p21 immunohistochemistry. Pathol Int 2010; 60: 175-83.
8. Bruix J, Sherman M, Llovet JM etal. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001; 35: 421-30.
9. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: A proposal for grading and staging the histological lesions. Am J Gastroenterol 1999; 94: 2467-74.
10. Kleiner DE, Brunt EM, van Natta M etal. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005; 41: 1313-21.
11. Pohl A, Behling C, Oliver D, Kilani M, Monson P, Hassanein T. Serum aminotransferase levels and platelet counts as predictors of degree of fibrosis in chronic hepatitis C virus infection. Am J Gastroenterol 2001; 96: 3142-6.
12. Wiemann SU, Satyanarayana A, Tsahuridu M etal. Hepatocyte telomere shortening and senescence are general markers of human liver cirrhosis. FASEB J 2002; 16: 935-42.
13. Nakajima T, Moriguchi M, Katagishi T etal. Premature telomere shortening and impaired regenerative response in hepatocytes of individuals with NAFLD. Liver Int 2006; 26: 23-31.
14. von Zglinicki T. Oxidative stress shortens telomeres. Trends Biochem Sci 2002; 27: 339-44.
15. Plentz RR, Park YN, Lechel A etal. Telomere shortening and inactivation of cell cycle checkpoints characterize human hepatocarcinogenesis. Hepatology 2007; 45: 968-76.
16. Nishida N, Nagasaka T, Nishimura T, Ikai I, Boland CR, Goel A. Aberrant methylation of multiple tumor suppressor genes in aging liver, chronic hepatitis, and hepatocellular carcinoma. Hepatology 2008; 47: 908-18.
17. Yokoi Y, Suzuki S, Baba S, Inaba K, Konno H, Nakamura S. Clinicopathological features of hepatocellular carcinomas (HCCs) arising in patients without chronic viral infection or alcohol abuse: A retrospective study of patients undergoing hepatic resection. J Gastroenterol 2005; 40: 274-82.
18. Abe H, Yoshizawa K, Kitahara T, Aizawa R, Matsuoka M, Aizawa Y. Etiology of non-B non-C hepatocellular carcinoma in the eastern district of Tokyo. J Gastroenterol 2008; 43: 967-74.
19. Hayashi T, Hirai S, Shimatani A etal. Clinicopathological characteristics of surgically treated patients with non-B non-C type hepatocellular carcinoma. (in Japanese) Kanzo 2010; 51: 697-705.
20. Alexia C, Fallot G, Lasfer M, Schweizer-Groyer G, Groyer A. An evaluation of the role of insulin-like growth factors (IGF) and of type-I IGF receptor signaling in hepatocarcinogenesis and in the resistance of hepatocarcinoma cells against drug-induced apoptosis. Biochem Pharmacol 2004; 68: 1003-15.
21. Tanaka S, Honda M, Wu B, Kazumi T. Clinical features of normal weight Japanese patients with type 2 diabetes who had formerly been obese. J Atheroscler Thromb 2011; 18: 115-21.